Cargando…
Federal 340B Program Payment Scheme for Drugs Designated As Orphan Products: Congressional Clarification Needed to Close the Government-Industry Revolving Door
Autores principales: | Yang, Y. Tony, Chen, Brian, Bennett, Charles L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366246/ https://www.ncbi.nlm.nih.gov/pubmed/27998222 http://dx.doi.org/10.1200/JCO.2016.68.2989 |
Ejemplares similares
-
COVID-19 in the UK and Occupational Health and Safety: Predictable not Inevitable Failures by Government, and Trade Union and Nongovernmental Organization Responses
por: Watterson, Andrew
Publicado: (2020) -
Illusions of a revolving door : plays, teatro /
por: Pietri, Pedro, 1944-
Publicado: (1992) -
Hepatic Encephalopathy-Related Hospitalizations in Cirrhosis: Transition of Care and Closing the Revolving Door
por: Frenette, Catherine T., et al.
Publicado: (2021) -
Southeast Asia needs a revolving fund for vaccines
por: Seraj Ahmad, Fariza Nasreen, et al.
Publicado: (2022) -
Good reasons to vaccinate: mandatory or payment for risk?
por: Savulescu, Julian
Publicado: (2021)